Terug
31
43
53
Dagbereik
€ 56,34
€ 57,48
52-Weeksbereik
€ 30,04
€ 62,90
Volume
206.351
50D / 200D Gem.
€ 54,20
/
€ 51,68
Vorige Slotkoers
€ 56,33
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 14,2 | 11,2 |
| P/B | 7,1 | 1,4 |
| ROE % | 61,6 | 10,7 |
| Net Margin % | 8,6 | 5,2 |
| Rev Growth 5Y % | 21,3 | 8,1 |
| D/E | 0,4 | 0,8 |
Koersdoel Analisten
Hold
€ 69,67
+21.2%
Low: € 55,00
High: € 78,00
Forward K/W
12,17
Forward WPA
€ 4,54
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,50B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,72
€ 6,63 – € 6,84
|
1,94B | 1 |
| FY2029 |
€ 5,97
€ 5,89 – € 6,08
|
1,84B | 1 |
| FY2028 |
€ 5,24
€ 5,14 – € 5,35
|
1,69B | 2 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 21,29% annually over 5 years — strong growth
Earnings grew 21,01% over the past year
ROE of 61,55% indicates high profitability
Debt/Equity of 0,35 — conservative balance sheet
Generating 153,34M in free cash flow
P/E of 14,22 — trading at a low valuation
Groei
Revenue Growth (5Y)
21,29%
Revenue (1Y)9,87%
Earnings (1Y)21,01%
FCF Growth (3Y)17,32%
Kwaliteit
Return on Equity
61,55%
ROIC36,26%
Net Margin8,63%
Op. Margin11,29%
Veiligheid
Debt / Equity
0,35
Current Ratio1,74
Interest Coverage23,21
Waardering
P/E Ratio
14,22
Forward P/E12,17
P/B Ratio7,11
EV/EBITDA10,04
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,87% | Revenue Growth (3Y) | 14,31% |
| Earnings Growth (1Y) | 21,01% | Earnings Growth (3Y) | 131,60% |
| Revenue Growth (5Y) | 21,29% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,48B | Net Income (TTM) | 127,72M |
| ROE | 61,55% | ROA | 20,43% |
| Gross Margin | 20,51% | Operating Margin | 11,29% |
| Net Margin | 8,63% | Free Cash Flow (TTM) | 153,34M |
| ROIC | 36,26% | FCF Growth (3Y) | 17,32% |
| Safety | |||
| Debt / Equity | 0,35 | Current Ratio | 1,74 |
| Interest Coverage | 23,21 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 14,22 | Forward P/E | 12,17 |
| P/B Ratio | 7,11 | P/S Ratio | 1,23 |
| PEG Ratio | 0,64 | Forward PEG | N/A |
| EV/EBITDA | 10,04 | Fwd EV/EBITDA | 4,05 |
| Forward P/S | 1,21 | Fwd Earnings Yield | 8,22% |
| FCF Yield | 8,44% | ||
| Market Cap | 1,82B | Enterprise Value | 1,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,48B | 1,35B | 1,13B | 800,64M | 684,00M |
| Net Income | 127,72M | 105,55M | 23,81M | -45,76M | -289.000,0 |
| EPS (Diluted) | 3,88 | 3,16 | 0,74 | -1,34 | -0,03 |
| Gross Profit | 303,51M | 256,16M | 138,85M | 36,55M | 72,14M |
| Operating Income | 167,17M | 139,33M | 51,66M | -40,70M | 6,52M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 625,26M | 524,89M | 417,77M | 366,13M | 356,02M |
| Total Liabilities | 369,84M | 365,33M | 377,77M | 364,74M | 388,68M |
| Shareholders' Equity | 255,42M | 159,56M | 40,00M | 1,38M | -32,66M |
| Total Debt | 90,32M | 95,98M | 131,91M | 174,48M | 220,82M |
| Cash & Equivalents | 229,31M | 127,69M | 78,99M | 10,48M | 11,71M |
| Current Assets | 411,63M | 323,38M | 236,06M | 174,48M | 156,07M |
| Current Liabilities | 236,80M | 235,97M | 229,62M | 164,77M | 124,78M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#813 of 1052
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#225 of 332
Custom
Lower Risk
#37 of 140
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026
